Home / Central Data Catalog / IMPACT_EVALUATION / NGA_2017_HRBFIE-EL_V01_M
impact_evaluation

State Health Investment Project: Impact Evaluation Endline Survey, 2017

Nigeria, 2017
Get Microdata
Reference ID
NGA_2017_HRBFIE-EL_v01_M
DOI
https://doi.org/10.48529/bct1-ga12
Producer(s)
Eeshani Kandpal (World Bank)
Collection(s)
Impact Evaluation Surveys Fragility, Conflict and Violence
Metadata
Documentation in PDF DDI/XML JSON
Created on
Aug 09, 2021
Last modified
Aug 09, 2021
Page views
262595
Downloads
10874

Data file: staff_roster_noid.dta

This file contains data from the Healthcare Provider Interviews (HF7) Questionnaire on the following topics/sections:
- Healthcare provider satisfaction
- Staff training
- Hours and duties
- Salary
- Other compensation
- Internal and external supervision
- Supplemental income
- Whole well-being index
- Healthcare provider satisfaction
- Personal drive
- Innovation
- Staff knowledge
- Protocol-based vignettes
- PBF knowledge
- Partograph

Cases: 3222
Variables: 633

Variables

HF7_Q1104_oth
Other;specify
HF7_Q1105__1
11.05: Imagine a situation where there are not enough HEALTH CARE PROVIDERs in t
HF7_Q1105__2
11.05: Imagine a situation where there are not enough HEALTH CARE PROVIDERs in t
HF7_Q1105__3
11.05: Imagine a situation where there are not enough HEALTH CARE PROVIDERs in t
HF7_Q1105__4
11.05: Imagine a situation where there are not enough HEALTH CARE PROVIDERs in t
HF7_Q1105__5
11.05: Imagine a situation where there are not enough HEALTH CARE PROVIDERs in t
HF7_Q1105__6
11.05: Imagine a situation where there are not enough HEALTH CARE PROVIDERs in t
HF7_Q1105__7
11.05: Imagine a situation where there are not enough HEALTH CARE PROVIDERs in t
HF7_Q1105__8
11.05: Imagine a situation where there are not enough HEALTH CARE PROVIDERs in t
HF7_Q1105_oth
Other;specify
HF7_Q1201
Q12.01: IS THE STAFF A SERVICE PROVIDER (ANY CLINICAL SERVICE)?
HF7_Q1202A1
Q12.02a_1: BCG in weeks
HF7_Q1202A2
Q12.02a: Is %HF7_Q1202A1% in weeks or months?
HF7_Q1202B1
Q12.02b_1: Pentavalent1 in weeks
HF7_Q1202B2
Q12.02b: Is %HF7_Q1202B1% in weeks or months?
HF7_Q1202C1
Q12.02c: At what age should a child receive Pentavalent 2 vaccines?
HF7_Q1202C2
Q12.02c: Is %HF7_Q1202C1% in weeks or months?
HF7_Q1202D1
Q12.02d: At what age should a child receive DPT2 vaccines?
HF7_Q1202D2
Q12.02d: Is %HF7_Q1202D1% in weeks or months?
HF7_Q1202E1
Q12.02e: At what age should a child receive Yellow Fever vaccines?
HF7_Q1202E2
Q12.02e: Is %HF7_Q1202E1% in weeks or months?
HF7_Q1202F1
Q12.02f: At what age should a child receive Measles vaccines?
HF7_Q1202F2
Q12.02f: Is %HF7_Q1202F1% in weeks or months?
HF7_Q1203__1
Q12.03: What are the danger signs of tuberculosis?:LOSS OF WEIGHT
HF7_Q1203__2
Q12.03: What are the danger signs of tuberculosis?:LOSS OF APPETITE
HF7_Q1203__3
Q12.03: What are the danger signs of tuberculosis?:FEVER
HF7_Q1203__4
Q12.03: What are the danger signs of tuberculosis?:COUGH FOR MORE THAN 15 DAYS
HF7_Q1203__5
Q12.03: What are the danger signs of tuberculosis?:NIGHT SWEATING
HF7_Q1204
Q12.04: Imagine a mother brings in her 9 month old child for routine immunizatio
HF7_Q1205
Q12.05: Do you feel comfortable providing Sexual and Reproductive Health Service
HF7_Q1206
Q12.06: Do unmarried adolescents need permission from a family member to use ASR
HF7_Q1207__1
Q12.07: If a 13 year old female came to you for contraceptives what would you do
HF7_Q1207__2
Q12.07: If a 13 year old female came to you for contraceptives what would you do
HF7_Q1207__3
Q12.07: If a 13 year old female came to you for contraceptives what would you do
HF7_Q1207__4
Q12.07: If a 13 year old female came to you for contraceptives what would you do
HF7_Q1207__5
Q12.07: If a 13 year old female came to you for contraceptives what would you do
HF7_Q1207__6
Q12.07: If a 13 year old female came to you for contraceptives what would you do
HF7_Q1208__1
Q12.08: Do you know the policies related to Sexual and Reproductive Health servi
HF7_Q1208__2
Q12.08: Do you know the policies related to Sexual and Reproductive Health servi
HF7_Q1208__3
Q12.08: Do you know the policies related to Sexual and Reproductive Health servi
HF7_Q1209__1
Q12.09: CASE SCENARIO 1:GIVE SP (E.G. FANSIDAR, AMALAR, MALOXINE, MALDOX) AS DI
HF7_Q1209__2
Q12.09: CASE SCENARIO 1:COUNSEL HER TO SLEEP UNDER LONG LASTING INSECTICIDE TRE
HF7_Q1209__3
Q12.09: CASE SCENARIO 1:COUNSEL HER TO COME FOR SECOND DOSE OF SP
HF7_Q1209__4
Q12.09: CASE SCENARIO 1:ADVICE ON ADEQUATE NUTRITION
HF7_Q1209__5
Q12.09: CASE SCENARIO 1:EDUCATE HER TO SCREEN WINDOWS AND DOORS WITH NET
HF7_Q1209__6
Q12.09: CASE SCENARIO 1:PROVIDE ADVICE ON ENVIRONMENTAL SANITATION AND HYGIENE
HF7_Q1209__7
Q12.09: CASE SCENARIO 1:ENCOURAGE ON THE USE OF INSECTICIDE
HF7_Q1210__1
Q12.10: CASE SCENARIO 2:TREAT FOR MALARIA WITH ARTEMISININ-BASED COMBINATION THE
HF7_Q1210__8
Q12.10: CASE SCENARIO 2:TREAT MALARIA WITH ARTESUNATE (AS)/QUININE/ARTEMETHER TH
HF7_Q1210__2
Q12.10: CASE SCENARIO 2:COUNSEL/HEALTH EDUCATE ON HOW TO COMPLETE TREATMENT AND
HF7_Q1210__3
Q12.10: CASE SCENARIO 2:REFER TO THE NEAREST HOSPITAL
HF7_Q1210__4
Q12.10: CASE SCENARIO 2:ENCOURAGE FLUID INTAKE
HF7_Q1210__5
Q12.10: CASE SCENARIO 2:TEPID SPONGE AND TEMPERATURE, PULSE, RESPIRATION (TPR)
HF7_Q1210__6
Q12.10: CASE SCENARIO 2:ADVISE PATIENT TO RETURN TO PHC AFTER TWO DAYS IF THERE
HF7_Q1210__7
Q12.10: CASE SCENARIO 2:ADVISE PATIENT TO RETURN TO PHC IMMEDIATELY IF THE CONDI
HF7_Q1211__1
Q12.11: CASE SCENARIO 3:GIVE RECTAL DIAZEPAM OR SLOW IV DIAZEPAM OR PARAALDEHYDE
HF7_Q1211__2
Q12.11: CASE SCENARIO 3:CIRCULATION, COMA, CONVULSION AND DEHYDRATION
HF7_Q1211__3
Q12.11: CASE SCENARIO 3:CARRY OUT A THOROUGH EXAMINATION OF THE PATIENT COVERING
HF7_Q1211__4
Q12.11: CASE SCENARIO 3:CARRY OUT BEDSIDE TEST FOR BLOOD SUGAR AND TREAT HYPOGLA
HF7_Q1211__5
Q12.11: CASE SCENARIO 3:DO MALARIA RDT AND/OR MICROSCOPY TO IDENTIFY PARASITE TY
HF7_Q1211__6
Q12.11: CASE SCENARIO 3:ESTIMATE HB CONCENTRATION AND HCT. TRANSFUSE BLOOD/PCV I
HF7_Q1211__7
Q12.11: CASE SCENARIO 3:DO FULL BLOOD COUNT
HF7_Q1211__8
Q12.11: CASE SCENARIO 3:DO UREA OR CRAETININE AND PLASMA ELECTROLYTES
HF7_Q1211__9
Q12.11: CASE SCENARIO 3:DO LUMBER PUNCTURE IF INDICATED
HF7_Q1211__10
Q12.11: CASE SCENARIO 3:DO CHEST X RAY
HF7_Q1211__11
Q12.11: CASE SCENARIO 3:GIVE OXYGEN IF THERE ARE SIGNS OF METABOLIC ACIDOSIS
HF7_Q1211__12
Q12.11: CASE SCENARIO 3:ESTABLISH IV LINE AND RESTORE CIRCULATING VOLUME WITH SA
HF7_Q1211__13
Q12.11: CASE SCENARIO 3:INSERT NG TUBE TO MINIMIZE RISK OF ASPIRATION PNEUMONIA
HF7_Q1211__14
Q12.11: CASE SCENARIO 3:INSERT URINARY CATHETER IF RENAL FAILURE IS SUSPECTED OR
HF7_Q1211__15
Q12.11: CASE SCENARIO 3:GIVE BROAD SPECTRUM ANTIBIOTIC
HF7_Q1211__16
Q12.11: CASE SCENARIO 3:TREAT MALARIA WITH ARTESUNATE/QUININE/ARTEMETHER THROUGH
HF7_Q1212__1
Q12.12 CASE SCENARIO 4:RECOMMENDS URGENT REFERRAL TO A HOSPITAL
HF7_Q1212__2
Q12.12 CASE SCENARIO 4:ADMINISTER RINGER LACTATE OR NORMAL SALINE IV SOLUTION
HF7_Q1212__3
Q12.12 CASE SCENARIO 4:ADMINISTER LIQUID BY NASO-GASTRIC TUBE
HF7_Q1212__4
Q12.12 CASE SCENARIO 4:INJECT ONE DOSE OF AN INJECTABLE ANTIBIOTIC
HF7_Q1212__5
Q12.12 CASE SCENARIO 4:INJECT ONE DOSE OF A SECOND ANTIBIOTIC (IF REFERRAL IS DI
HF7_Q1212__6
Q12.12 CASE SCENARIO 4:PRESCRIBE INJECTABLE ANTIBIOTIC FOR FIVE DAYS
HF7_Q1212__7
Q12.12 CASE SCENARIO 4:GIVE ONE DOSE OF AN ORAL ANTIBIOTIC
HF7_Q1212__8
Q12.12 CASE SCENARIO 4:PRESCRIBE ORAL ANTIBIOTICS FOR FIVE DAYS
HF7_Q1212__9
Q12.12 CASE SCENARIO 4:GIVE ONE DOSE OF ORAL ANTIMALARIAL
HF7_Q1212__10
Q12.12 CASE SCENARIO 4:PRESCRIBE QUININE FOR FIVE DAYS
HF7_Q1212__11
Q12.12 CASE SCENARIO 4:PRESCRIBE ORAL ANTIMALARIALS FOR 3 DAYS
HF7_Q1212__12
Q12.12 CASE SCENARIO 4:ADMINISTER ORS AT THE FACILITY
HF7_Q1212__13
Q12.12 CASE SCENARIO 4:ADVISE ON GIVING ORS ON THE WAY TO HOSPITAL
HF7_Q1212__14
Q12.12 CASE SCENARIO 4:PRESCRIBE ORS FOR HOME TREATMENT
HF7_Q1212__15
Q12.12 CASE SCENARIO 4:GIVE ONE DOSE OF PARACETAMOL
HF7_Q1212__16
Q12.12 CASE SCENARIO 4:PRESCRIBE PARACETAMOL FOR HOME TREATMENT
HF7_Q1212__17
Q12.12 CASE SCENARIO 4:GIVE ONE DOSE OF VITAMIN A
HF7_Q1212__18
Q12.12 CASE SCENARIO 4:TREAT TO PREVENT LOW BLOOD SUGAR
HF7_Q1212__19
Q12.12 CASE SCENARIO 4:RECOMMENDS TO CONTINUE BREASTFEEDING
HF7_Q1212__20
Q12.12 CASE SCENARIO 4:RECOMMENDS TO GIVE FOOD AND FLUIDS OTHER THAN BREASTMILK
HF7_Q1213__1
Q12.13: CASE SCENARIO 5:REFER URGENTLY TO A HOSPITAL
HF7_Q1213__2
Q12.13: CASE SCENARIO 5:ADMINISTER RINGER LACTATE OR NORMAL SALINE IV SOLUTION
HF7_Q1213__3
Q12.13: CASE SCENARIO 5:ADMINISTER LIQUID BY NASO-GASTRIC TUBE
HF7_Q1213__4
Q12.13: CASE SCENARIO 5:INJECT ONE DOSE OF AN INJECTABLE ANTIBIOTIC
HF7_Q1213__5
Q12.13: CASE SCENARIO 5:INJECT ONE DOSE OF A SECOND ANTIBIOTIC
HF7_Q1213__6
Q12.13: CASE SCENARIO 5:PRESCRIBE INJECTABLE ANTIBIOTIC FOR FIVE DAYS
HF7_Q1213__7
Q12.13: CASE SCENARIO 5:GIVE ONE DOSE OF AN ORAL ANTIBIOTIC
HF7_Q1213__8
Q12.13: CASE SCENARIO 5:PRESCRIBE ORAL ANTIBIOTICS FOR FIVE DAYS
HF7_Q1213__9
Q12.13: CASE SCENARIO 5:GIVE ONE DOSE OF ORAL ANTIMALARIAL
HF7_Q1213__10
Q12.13: CASE SCENARIO 5:PRESCRIBE QUININE FOR FIVE DAYS
HF7_Q1213__11
Q12.13: CASE SCENARIO 5:PRESCRIBE ORAL ANTIMALARIALS FOR 3 DAYS
HF7_Q1213__12
Q12.13: CASE SCENARIO 5:ADMINISTER ORS AT THE FACILITY
HF7_Q1213__13
Q12.13: CASE SCENARIO 5:ADVISE ON GIVING ORS ON THE WAY TO HOSPITAL
HF7_Q1213__14
Q12.13: CASE SCENARIO 5:PRESCRIBE ORS FOR HOME TREATMENT
HF7_Q1213__15
Q12.13: CASE SCENARIO 5:GIVE ONE DOSE OF PARACETAMOL
HF7_Q1213__16
Q12.13: CASE SCENARIO 5:PRESCRIBE PARACETAMOL FOR HOME TREATMENT
HF7_Q1213__17
Q12.13: CASE SCENARIO 5:GIVE ONE DOSE OF VITAMIN A
HF7_Q1213__18
Q12.13: CASE SCENARIO 5:TREAT TO PREVENT LOW BLOOD SUGAR
HF7_Q1213__19
Q12.13: CASE SCENARIO 5:RECOMMEND TO CONTINUE BREASTFEEDING
HF7_Q1213__20
Q12.13: CASE SCENARIO 5:RECOMMEND TO GIVE FOOD AND FLUIDS OTHER THAN BREASTMILK
HF7_Q1213__21
Q12.13: CASE SCENARIO 5:RECOMMEND TO KEEP CHILD WARM
HF7_Q1214__1
Q12.14: CASE SCENARIO 6:VAGINAL BLEEDING
HF7_Q1214__2
Q12.14: CASE SCENARIO 6:CONVULSIONS
HF7_Q1214__3
Q12.14: CASE SCENARIO 6:SEVERE HEADACHE OR BLURRED VISION
HF7_Q1214__4
Q12.14: CASE SCENARIO 6:FEVER AND TOO WEAK TO GET OUT OF BED
HF7_Q1214__5
Q12.14: CASE SCENARIO 6:SEVERE ABDOMINAL PAIN
HF7_Q1214__6
Q12.14: CASE SCENARIO 6:BABY PRESENT WITH BUTTOCKS, HANDS AND CORD
HF7_Q1214__7
Q12.14: CASE SCENARIO 6:LABOUR PROLONG MORE THAN 12 HOURS
HF7_Q1214__8
Q12.14: CASE SCENARIO 6:PREMATURE RUPTURE OF MEMBRANE
HF7_Q1214__9
Q12.14: CASE SCENARIO 6:PLACENTA DELAY MORE THAN 30 MINUTES
HF7_Q1214__10
Q12.14: CASE SCENARIO 6:SWELLING OF FACE, FINGERS, LEGS
HF7_Q1301__1
13.01A.NUMBER OF PRIOR PREGNANCIES:NUMBER OF PRIOR PREGNANCIES
HF7_Q1301__2
13.01A.NUMBER OF PRIOR PREGNANCIES:NUMBER OF LIVE BIRTHS
HF7_Q1301__3
13.01A.NUMBER OF PRIOR PREGNANCIES:NUMBER OF MISCARRIAGES/STILLBIRTHS/ABORTIONS
HF7_Q1301__4
13.01A.NUMBER OF PRIOR PREGNANCIES:ANY BLEEDING DURING PREVIOUS LABOR
HF7_Q1301__5
13.01A.NUMBER OF PRIOR PREGNANCIES:HOW WAS THE LAST CHILD DELIVERED? (NATURAL? C
HF7_Q1301__6
13.01A.NUMBER OF PRIOR PREGNANCIES:BIRTH WEIGHT OF PREVIOUS CHILD
HF7_Q1301__7
13.01A.NUMBER OF PRIOR PREGNANCIES:HISTORY OF GENETIC ANOMALIES
HF7_Q1301__8
13.01A.NUMBER OF PRIOR PREGNANCIES:TETANUS IMMUNIZATIONS?
HF7_Q1301__9
13.01A.NUMBER OF PRIOR PREGNANCIES:BIRTH INTERVAL
HF7_Q1301__10
13.01A.NUMBER OF PRIOR PREGNANCIES:CONVULSIONS
HF7_Q1302__1
LAST MENSTRUAL PERIOD (LMP):LAST MENSTRUAL PERIOD (LMP)
HF7_Q1302__2
LAST MENSTRUAL PERIOD (LMP):ANY HEALTH PROBLEMS NOW?
HF7_Q1302__3
LAST MENSTRUAL PERIOD (LMP):ANY CONTRACTIONS?
HF7_Q1302__4
LAST MENSTRUAL PERIOD (LMP):ANY VAGINAL BLEEDING?
HF7_Q1302__5
LAST MENSTRUAL PERIOD (LMP):ANY WEIGHT LOSS/GAIN?
HF7_Q1302__6
LAST MENSTRUAL PERIOD (LMP):ANY NAUSEA OR VOMITING?
HF7_Q1302__7
LAST MENSTRUAL PERIOD (LMP):TAKING MEDICATIONS NOW?
HF7_Q1302__8
LAST MENSTRUAL PERIOD (LMP):TETANUS IMMUNIZATIONS?
HF7_Q1303__1
ANY HISTORY OF HIGH BLOOD PRESSURE?:ANY HISTORY OF HIGH BLOOD PRESSURE?
HF7_Q1303__2
ANY HISTORY OF HIGH BLOOD PRESSURE?:ANY HISTORY OF DIABETES?
HF7_Q1303__3
ANY HISTORY OF HIGH BLOOD PRESSURE?:ANY PREVIOUS STI, INCLUDING HIV?
HF7_Q1303__4
ANY HISTORY OF HIGH BLOOD PRESSURE?:ANY PREVIOUS IUCD OR CONTRACEPTIVE USE?
HF7_Q1303__5
ANY HISTORY OF HIGH BLOOD PRESSURE?:ANY PAP SMEARS?
HF7_Q1303__6
ANY HISTORY OF HIGH BLOOD PRESSURE?:ANY HEART DISEASE, LIVER DISEASE, MALARIA, G
HF7_Q1303__7
ANY HISTORY OF HIGH BLOOD PRESSURE?:FAMILY HISTORY OF HEREDITARY D ISEASE?
HF7_Q1303__8
ANY HISTORY OF HIGH BLOOD PRESSURE?:ANY ALLERGIES TO MEDICATIONS?
HF7_Q1303__9
ANY HISTORY OF HIGH BLOOD PRESSURE?:PRESENT/CURRENT SMOKER?
HF7_Q1303__10
ANY HISTORY OF HIGH BLOOD PRESSURE?:ANY HISTORY OF ALCOHOL USE?
HF7_Q1303__11
ANY HISTORY OF HIGH BLOOD PRESSURE?:ANY HISTORY OF ILLICIT DRUG USE?
HF7_Q1303__12
ANY HISTORY OF HIGH BLOOD PRESSURE?:BLOOD TRANSFUSION
HF7_Q1303__13
ANY HISTORY OF HIGH BLOOD PRESSURE?:JAUNDICE
HF7_Q1304__1
BODY HEIGHT:BODY HEIGHT
HF7_Q1304__2
BODY HEIGHT:BODY WEIGHT
HF7_Q1304__3
BODY HEIGHT:BLOOD PRESSURE
HF7_Q1304__4
BODY HEIGHT:TEMPERATURE
HF7_Q1304__5
BODY HEIGHT:RESPIRATORY RATE
HF7_Q1304__6
BODY HEIGHT:PALPATE ABDOMEN
HF7_Q1304__7
BODY HEIGHT:LISTEN TO FETAL HEARTBEAT
HF7_Q1304__8
BODY HEIGHT:PELVIC EXAMINATION
HF7_Q1304__9
BODY HEIGHT:CHECK FOR OEDEMA/SWELLING OF THE FEET, ANKLE OR FACE
HF7_Q1304__10
BODY HEIGHT:MEASURE SIZE OF WOMB (FUNDAL HEIGHT OR UTERINE HEIGHT)
HF7_Q1304__11
BODY HEIGHT:ADMINISTER TETANUS TOXOID
HF7_Q1304__12
BODY HEIGHT:EYE FOR JAUNDICE/PALLOR
HF7_Q1304__13
BODY HEIGHT:NECK FOR GOITRE
HF7_Q1304__14
BODY HEIGHT:BREAST FOR SORE, INVERSION OR SWOLLEN
HF7_Q1304__15
BODY HEIGHT:VERICOSE VEIN IN THE LEGS
HF7_Q1305__1
PREGNANCY TEST:PREGNANCY TEST
HF7_Q1305__2
PREGNANCY TEST:HEMOGLOBIN TEST
HF7_Q1305__3
PREGNANCY TEST:URINE TEST FOR DIABETES
HF7_Q1305__4
PREGNANCY TEST:URINE PROTEIN
HF7_Q1305__5
PREGNANCY TEST:ULTRASOUND
HF7_Q1305__6
PREGNANCY TEST:BLOOD PLATELETS COUNT
HF7_Q1305__7
PREGNANCY TEST:LIVER ENZYMES
HF7_Q1305__8
PREGNANCY TEST:SERUM UREA AND CREATININE
HF7_Q1305__9
PREGNANCY TEST:HIV TEST
HF7_Q1305__10
PREGNANCY TEST:STI TEST - SYPHILLIS AND/OR GONORRHEA
HF7_Q1305__11
PREGNANCY TEST:RUBELLA ANTIBODIES
HF7_Q1305__12
PREGNANCY TEST:BLOOD GROUPING AND CROSS-MATCHIING
HF7_Q1306__1
13.06: What would you prescribe/provide to Mrs. Sibeso?:INSECTICIDE TREATED MOS
HF7_Q1306__2
13.06: What would you prescribe/provide to Mrs. Sibeso?:IRON / FOLIC ACID SUPPL
HF7_Q1306__3
13.06: What would you prescribe/provide to Mrs. Sibeso?:ADMINISTER TETANUS TOXO
HF7_Q1306__4
13.06: What would you prescribe/provide to Mrs. Sibeso?:INTERMITTENT PREVENTIVE
HF7_Q1307__1
13.07: What kind of advice would you give to Mrs. Sibeso?:NUTRITION
HF7_Q1307__2
13.07: What kind of advice would you give to Mrs. Sibeso?:IRON / FOLIC ACID SUP
HF7_Q1307__3
13.07: What kind of advice would you give to Mrs. Sibeso?:DANGER SIGNS FOR EMER
HF7_Q1307__4
13.07: What kind of advice would you give to Mrs. Sibeso?:BREASTFEEDING
HF7_Q1307__5
13.07: What kind of advice would you give to Mrs. Sibeso?:CONTRACEPTION
HF7_Q1307__6
13.07: What kind of advice would you give to Mrs. Sibeso?:HIV VOLUNTARY COUNSEL
HF7_Q1307__7
13.07: What kind of advice would you give to Mrs. Sibeso?:USE OF INSECTICIDE TR
HF7_Q1308__1
13.08: What follow-up action would you take for Mrs. Sibeso?:COMPLETE PRENATAL
HF7_Q1308__2
13.08: What follow-up action would you take for Mrs. Sibeso?:SCHEDULE ANOTHER P
HF7_Q1308__3
13.08: What follow-up action would you take for Mrs. Sibeso?:SCHEDULE INSTITUTI
HF7_Q1308__4
13.08: What follow-up action would you take for Mrs. Sibeso?:BIRTH PREPAREDNESS
HF7_Q1402
15.02. Are you aware that this facility participates in the Nigeria State Health
HF7_Q1401A__1
14.01A. Which of the following indicators are incentivized by the Complementary
HF7_Q1401A__2
14.01A. Which of the following indicators are incentivized by the Complementary
HF7_Q1401A__3
14.01A. Which of the following indicators are incentivized by the Complementary
HF7_Q1401A__4
14.01A. Which of the following indicators are incentivized by the Complementary
HF7_Q1401A__5
14.01A. Which of the following indicators are incentivized by the Complementary
HF7_Q1401A__6
14.01A. Which of the following indicators are incentivized by the Complementary
HF7_Q1401A__7
14.01A. Which of the following indicators are incentivized by the Complementary
HF7_Q1401A__8
14.01A. Which of the following indicators are incentivized by the Complementary
HF7_Q1401B__1
14.01B. Which of the following indicators are incentivized by the Minimum Packag
HF7_Q1401B__2
14.01B. Which of the following indicators are incentivized by the Minimum Packag
HF7_Q1401B__3
14.01B. Which of the following indicators are incentivized by the Minimum Packag
HF7_Q1401B__4
14.01B. Which of the following indicators are incentivized by the Minimum Packag
HF7_Q1401B__5
14.01B. Which of the following indicators are incentivized by the Minimum Packag
HF7_Q1401B__6
14.01B. Which of the following indicators are incentivized by the Minimum Packag
HF7_Q1401B__7
14.01B. Which of the following indicators are incentivized by the Minimum Packag
HF7_Q1401B__8
14.01B. Which of the following indicators are incentivized by the Minimum Packag
HF7_Q1403
15.03 Can you tell me how much top-up payment, if any, YOUR FACILITY received in
HF7_Q1404A__1
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__2
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__3
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__4
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__5
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__6
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__7
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__8
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__9
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__10
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__11
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__12
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__13
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__14
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__15
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__16
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__17
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__18
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__19
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__20
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__21
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__22
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__23
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__24
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__1
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__2
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__3
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__4
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__5
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__6
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__7
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__8
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__9
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__10
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__11
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__12
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__13
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__14
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__15
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__16
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__17
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__18
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__19
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__20
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__21
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__22
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1405__1
15.05 Generally speaking, what else determine the level of payment for services:
HF7_Q1405__2
15.05 Generally speaking, what else determine the level of payment for services:
HF7_Q1405__3
15.05 Generally speaking, what else determine the level of payment for services:
HF7_Q1405__4
15.05 Generally speaking, what else determine the level of payment for services:
HF7_Q1405__5
15.05 Generally speaking, what else determine the level of payment for services:
HF7_Q1405__6
15.05 Generally speaking, what else determine the level of payment for services:
HF7_Q1405__7
15.05 Generally speaking, what else determine the level of payment for services:
HF7_Q1405_os
14.05_Oth. Specify the other factor that determines the level of payment for ser
HF7_Q1406
15.06. In naira, can you tell me what the PBF fee for a NORMAL DELIVERY is?
HF7_Q1407
15.07. In naira, can you tell me what the PBF fee for a POSTNATAL CONSULTATION
HF7_Q1408
15.08. In naira, can you tell me what the PBF fee for a NEW CLIENT PUT UNDER ARV
HF7_Q1409
15.09. Are you aware that under the PBF program target levels are set for certai
HF7_Q1410
15.10 . Can you tell me what the percentage target is for 2017 for NORMAL DELIVE
HF7_Q1411
15.11 . Can you tell me what the percentage target is for 2017 for POSTNATAL CON
HF7_Q1412
15.12. Can you tell me what the percentage target is for 2017 for NEW PATIENTS
HF7_Q1413
15.13. Can you tell me the percentage quality bonus that health facilities can r
partograph_check
INTERVIEWER: PLEASE ASK THE RESPONDENT IF THEY KNOW HOW TO READ A PARTOGRAPH. YO
arm
INTERVIEWER: SELECT THE EXPERIMENT ARM FOR THE INTERVIEWER
correct
INTERVIEWER: SELECT WHETHER THE RESPONDENT WILL BE ASSIGNED TO OPTION 1 OR OPTIO
HF7_Q1501
15.01. Based on Mrs. Florence's partograph, your colleague suggests that you %Q1
HF7_Q1502__1
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__2
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__3
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__4
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__5
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__6
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__7
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__8
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__9
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__10
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__11
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__12
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__13
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__14
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__15
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__16
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502_os
15.02_Oth. Please specify other action
HF7_Q1503__1
15.03. Assume Mrs. Blessing is your patient. What clinically indicated actions w
HF7_Q1503__2
15.03. Assume Mrs. Blessing is your patient. What clinically indicated actions w
HF7_Q1503__3
15.03. Assume Mrs. Blessing is your patient. What clinically indicated actions w
HF7_Q1503__4
15.03. Assume Mrs. Blessing is your patient. What clinically indicated actions w
Total: 633
Back to Catalog

This site uses cookies to optimize functionality and give you the best possible experience. If you continue to navigate this website beyond this page, cookies will be placed on your browser. To learn more about cookies, click here.